Actithera Inc

Actithera, Inc. develops biotechnology solutions focused on radioligand therapy for cancer. The Company designs proprietary chemistry platforms, advances targeted radioligand therapies, and prepares compounds for clinical trials. Actithera Inc serves cancer patients with high unmet medical needs in Norway and the United States.